UA102519U - METHOD OF MODELING THE DIFFLENAC SODIUM EFFECTS ON RED BONE BRAIN INDICATORS IN THE EXPERIMENT - Google Patents

METHOD OF MODELING THE DIFFLENAC SODIUM EFFECTS ON RED BONE BRAIN INDICATORS IN THE EXPERIMENT

Info

Publication number
UA102519U
UA102519U UAU201405535U UAU201405535U UA102519U UA 102519 U UA102519 U UA 102519U UA U201405535 U UAU201405535 U UA U201405535U UA U201405535 U UAU201405535 U UA U201405535U UA 102519 U UA102519 U UA 102519U
Authority
UA
Ukraine
Prior art keywords
experiment
sodium
difflenac
indicators
modeling
Prior art date
Application number
UAU201405535U
Other languages
Russian (ru)
Ukrainian (uk)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to UAU201405535U priority Critical patent/UA102519U/en
Publication of UA102519U publication Critical patent/UA102519U/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Спосіб моделювання впливу диклофенаку натрію на морфо-функціональні показники червоного кісткового мозку білих лабораторних щурів в експерименті включає введення хімічної речовини в організм тварини та вивчення динамічних змін зі сторони морфологічних структур організму. Вводять диклофенак натрію у вигляді розчину для ін'єкцій із розрахунку 10 мг/кг маси тіла, після контрольного зважування тварини за допомогою шприца у шлунок щурів 1 раз на добу протягом семи днів.A method of simulating the effect of diclofenac sodium on morpho-functional parameters of the red bone marrow of white laboratory rats in an experiment involves the introduction of a chemical into an animal's body and the study of dynamic changes from the side of morphological structures of the body. Diclofenac sodium is administered as a solution for injection at the rate of 10 mg / kg body weight, after weighing the animal with a syringe in the stomach of rats once a day for seven days.

UAU201405535U 2014-05-23 2014-05-23 METHOD OF MODELING THE DIFFLENAC SODIUM EFFECTS ON RED BONE BRAIN INDICATORS IN THE EXPERIMENT UA102519U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201405535U UA102519U (en) 2014-05-23 2014-05-23 METHOD OF MODELING THE DIFFLENAC SODIUM EFFECTS ON RED BONE BRAIN INDICATORS IN THE EXPERIMENT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201405535U UA102519U (en) 2014-05-23 2014-05-23 METHOD OF MODELING THE DIFFLENAC SODIUM EFFECTS ON RED BONE BRAIN INDICATORS IN THE EXPERIMENT

Publications (1)

Publication Number Publication Date
UA102519U true UA102519U (en) 2015-11-10

Family

ID=54774044

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201405535U UA102519U (en) 2014-05-23 2014-05-23 METHOD OF MODELING THE DIFFLENAC SODIUM EFFECTS ON RED BONE BRAIN INDICATORS IN THE EXPERIMENT

Country Status (1)

Country Link
UA (1) UA102519U (en)

Similar Documents

Publication Publication Date Title
MX2021013880A (en) Proton-binding polymers for oral administration.
BR112017014361A2 (en) methods for perfecting cell therapy
AR097178A1 (en) DIAGNOSIS AND ANTI-CANCER THERAPIES THAT INCLUDE CANCEROSE MOTHER CELLS
MX2021004558A (en) Proton-binding polymers for oral administration.
EA201591679A1 (en) METHOD OF NON-TOXIC TREATMENT OF ABSTINENT, CAUSED BY MEDICINE
SG10201906400SA (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof
CL2016001510A1 (en) Stem cells derived from mammalian muscle
TN2015000498A1 (en) Modified release formulation
MX2019005160A (en) Pharmaceutical formulation.
EA201590232A1 (en) ANIMAL MODEL OF CRABBE'S DISEASE
UA102519U (en) METHOD OF MODELING THE DIFFLENAC SODIUM EFFECTS ON RED BONE BRAIN INDICATORS IN THE EXPERIMENT
UA102518U (en) A METHOD OF SIMULATION OF THE DICLOFENAC EFFECTS OF SODIUM ON RED BONE BRAIN RATES IN THE EXPERIMENT
UA102521U (en) METHOD OF SIMULATION OF THE INFLUENCE OF DICLOFENAC SODIUM ON THE MORPHO-FUNCTIONAL INDICATORS OF THE RED BONE BRAIN OF THE WHITE RATS IN THE EXPERIMENT
EA201990550A1 (en) OPHTHALMIC DRUG INCLUDING THE ASOLIC COMPOUND
UA102520U (en) METHOD OF SIMULATION OF THE INFLUENCE OF DICLOFENAC SODIUM ON MORPHO-FUNCTIONAL INDICES OF RED BONE BRAIN OF WHITE LABORATORY RATS IN EXPERTS
EA201600383A1 (en) METHOD AND PREPARATION FOR THE TREATMENT OF ARTHRITIS AND ARTHROSIS
RU2010124969A (en) METHOD FOR SIMULATION OF A JAW FILMONA
RU2013131344A (en) METHOD FOR PREPARING LIQUID WASTE OF PIG BREEDING COMPLEXES AND FARMS FOR AGRICULTURAL USE
RU2013101733A (en) METHOD OF SEDATION API-PHYTOCOMPOSITION
RU2016122805A (en) Method for modeling pleural empyema in experiment
UA98459U (en) The method of modeling drug liver disease comprising administering to rats
UA117545C2 (en) METHOD OF SIMULATION OF BATTLE HEPATOSIS
MX2018004295A (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof.
UA101492U (en) Method of stimulation of reproductive capacity of sows
A Esmaial et al. Study of Cholinesterase Activity in Adult Ewes Treated by the Anthelmintic Drug Levamisole